Samrat Pharmachem Ltd. News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Samrat Pharmachem Ltd. from all sources in a single place.

Load latest

Samrat Pharmachem Ltd.

20 Mar 2025

361.05

4.70%

SAST

Samrat Pharmachem Ltd-$ - 530125 - Closure of Trading Window

BSE India

The trading window of the company shall remain closed from Tuesday, April 1, 2025 till 48 hours after the declaration of the Audited Financial Results of the company for the year ended March 31, 2025.

pdf

Samrat Pharmachem Ltd.

04 Mar 2025

361.05

4.70%

Corp. Note

SAMRAT PHARMACHEM LTD.-$ - 530125 - Integrated Filing (Financial)

BSE India

Integrated Filing (Financial) for the quarter and nine months ended December 31, 2024

pdf

Samrat Pharmachem Ltd.

14 Feb 2025

361.05

4.70%

Company Update

SAMRAT PHARMACHEM LTD.-$ - 530125 - General Announcement-Outcome Of Board Meeting (14-02-2025)

BSE India

Due to inadvertence, the start and end time of the Board Meeting held today was input in Indian time (02:00 to 03:30) instead of international time zone (14:00 to 15:30) during the filing of outcome of board meeting under corporate announcements. Correct Start & End time is: Start: 14:00 hrs End: 15:30 hrs

pdf

Samrat Pharmachem Ltd.

14 Feb 2025

361.05

4.70%

Company Update

SAMRAT PHARMACHEM LTD.-$ - 530125 - Outcome Of The Board Meeting Held Today - 14-02-2024

BSE India

Due to inadvertence, the start & end time of Board meeting was input in Indian time (02:00 To 03:30) instead of international time zone (14:00 To 15:30). The correct date & time of board meeting is as under: Date of board meeting: 14-02-2025 Commencement time: 14:00 hrs End time: 15:30 hrs

pdf

Samrat Pharmachem Ltd.

14 Feb 2025

361.05

4.70%

Result

SAMRAT PHARMACHEM LTD.-$ - 530125 - Approval Of Un-Audited Financial Results For The Quarter Ended December …

BSE India

Approval of UFR 31-12-2024

pdf

Samrat Pharmachem Ltd.

14 Feb 2025

361.05

4.70%

Board Meeting

SAMRAT PHARMACHEM LTD.-$ - 530125 - Board Meeting Outcome for Outcome Of Board Meeting Held Today

BSE India

The Board has considered and took on record the Un-audited Financial Results for the quarter ended December 31, 2024

pdf

Samrat Pharmachem Ltd.

13 Jan 2025

361.05

4.70%

Company Update

SAMRAT PHARMACHEM LTD.-$ - 530125 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Certificate u/r 74(5) of SEBI (DP), Reg 2018 for the quarter ended December 31, 2024

pdf

Samrat Pharmachem Ltd.

13 Jan 2025

361.05

4.70%

Company Update

SAMRAT PHARMACHEM LTD.-$ - 530125 - Announcement under Regulation 30 (LODR)-Change in RTA

BSE India

The name of our RTA has changed from Link Intime India Private Limited to MUFG Intime India Private Limited effective from December 31, 2024.

pdf

Samrat Pharmachem Ltd.

31 Dec 2024

361.05

4.70%

SAST

SAMRAT PHARMACHEM LTD.-$ - 530125 - Closure of Trading Window

BSE India

The Trading Window of the company shall remain closed from Wednesday, January 1, 2025 till 48 hours after the declaration of Un-audited financial results of the company for the quarter ended December 31, 2024.

pdf

Samrat Pharmachem Ltd.

31 Dec 2024

361.05

4.70%

Board Meeting

SAMRAT PHARMACHEM LTD.-$ - 530125 - Board Meeting Intimation for Un-Audited Financial Results For The Quarter …

BSE India

SAMRAT PHARMACHEM LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2025 ,inter alia, to consider and approve the Un-audited financial results of the company for the quarter ended December 31, 2024

pdf

Is Samrat Pharmachem Ltd. worth buying?

46 Votes:

Buy 67.39%

Sell 13.04%

Hold 19.57%